XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 337 $ 159,847,229 $ (135,730,039) $ 24,117,527
Balance (in Shares) at Dec. 31, 2022 33,684,864      
Exercise of stock options and vesting of restricted stock units 6,844 6,844
Exercise of stock options and vesting of restricted stock units (in Shares) 34,728      
Stock-based compensation     924,898 924,898
Net loss     (5,628,758) (5,628,758)
Balance at Mar. 31, 2023 $ 337 160,778,972 (141,358,797) 19,420,512
Balance (in Shares) at Mar. 31, 2023 33,719,592      
Balance at Dec. 31, 2023 $ 648 170,652,160 (160,017,619) 10,635,189
Balance (in Shares) at Dec. 31, 2023 64,773,756      
Exercise of stock options and vesting of restricted stock units
Exercise of stock options and vesting of restricted stock units (in Shares) 12,228      
Stock-based compensation   654,024 654,024
Issuance of common stock at-the-market equity financing, net of offering costs of $54,137 $ 133 2,651,977 2,652,110
Issuance of common stock at-the-market equity financing, net of offering costs of $54,137 (in Shares) 13,302,681      
Issuance of common stock for pre-funded warrants in connection with the private placement offering, net of offering costs of $156. $ 103 (156) (53)
Issuance of common stock for pre-funded warrants in connection with the private placement offering, net of offering costs of $156. (in Shares) 10,365,989      
Net loss     (5,970,079) (5,970,079)
Balance at Mar. 31, 2024 $ 884 $ 173,958,005 $ (165,987,698) $ 7,971,191
Balance (in Shares) at Mar. 31, 2024 88,454,654